
Department of General Surgery (Division of Visceral Surgery)
Position: Associate Professor
ORCID: 0000-0002-3068-5050
T +43 1 06607267174
klaus.sahora@meduniwien.ac.at
Keywords
Carcinoma, Pancreatic Ductal; Exocrine Pancreatic Insufficiency; Pancreas; Pancreatectomy; Pancreatic Cyst; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis
Research group(s)
- Pancreatic Cancer Unit
Research Area: Diagnostic and treatment of pancreatic cancer and pancreatitis Intraductal papillary mucinous neoplasms Prehabilitation program before surgery
Members: - Pancreatic surgery
Head: Martin Schindl
Research Area: Body composition and inflammation in pancreatic neoplasms.
Members:
Research interests
My main research focus is to understand the importance of pancreatic cancer and neoplasic cystic lesions of the pancreas (ie. Intraductal papillary mucinous neoplasm IPMN; mucinous cystic neoplasm MCN) The research is designed to elucidate mechanisms underlying the different typs of pancreas cysts and to develop novel surgical approaches inpancreatic cancer surgery.
Selected publications
- Sahora, K. et al., 2013. Branch Duct Intraductal Papillary Mucinous Neoplasms. Annals of Surgery, 258(3), pp.466,
- Sahora, K. et al., 2014. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: Implications of minimal involvement of the main pancreatic duct. Surgery, 156(3), pp.611,
- Sahora, K. et al., 2015. Effects of Comorbidities on Outcomes of Patients With Intraductal Papillary Mucinous Neoplasms. Clinical Gastroenterology and Hepatology, 13(10), pp.1816,
- Sahora, K. et al., 2011. NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer. Surgery, 149(3), pp.311,
- Gruber, E.S. et al., 2019. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma F. X. Real, ed. PLOS ONE, 14(5), p.e0215915. Available at: http://dx.doi.org/10.1371/journal.pone.0215915.